Matropin 0.02 is a Product of the Generic Homatropine Hydrobromide

Matropin 0.02 belongs to the generic category of Homatropine Hydrobromide. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Matropin 0.02. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Homatropine Hydrobromide and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Matropin 0.02

Matropin 0.02 may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Matropin 0.02 is provided below to help users gain a clear understanding of this medicine.

What Is Matropin 0.02 Indications and Uses?

Homatropine Hydrobromide eye drops is indicated for use as a mydriatic and cycloplegic.

Pharmacology (Source, Chemical and Physical Composition) Of Matropin 0.02

Homatropine is a competitive muscarinic receptor antagonist with a bulky aromatic group in place of the acetyl group of acetylcholine. It is expected to act in similar manner as atropine, producing similar parasympatholytic effects. By blocking muscarinic receptors and cholinergic signalling pathways, homatropine blocks the response of the iris sphincter muscle and cause the pupil to become unresponsive to light upon dilation or mydriasis. It also blocks the accommodative muscle of the ciliary body to cholinergic stimulation.

Dosage And Administration of Matropin 0.02

For refraction: Instill two drops in the eye(s) and repeat 2-3 times at 5-10 minute intervals. For therapy: Instill 1-2 drops in the eye(s) every 3-4 hours.Use in children: Should not be used in children below the age of 3 months.

Drug Interactions of Matropin 0.02

Effects may be increased by drugs with antimuscarinic effect such as; some antihistamines; phenothiazines; antipsychotics; TCAs; MAOIs or parasympathomimetics.

Side Effects of Matropin 0.02

Hypersensitivity may occur as conjunctivitis.

Use During Pregnancy and Lactation

There are no adequate and well-controlled studies in pregnant women. Matropin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Homatropine is excreted in human milk. Caution should be exercised when Matropin is administered to a nursing mother.

Precautions And Warnings for Matropin 0.02

Should be used with caution in patients with prostatic enlargement and in patients suffering from paralytic ileus or pyloric stenosis.

Therapeutic Class

Mydriatic and Cycloplegic agents

Storage Conditions of It

Store in a cool & dry place, protect from light. Do not use longer than 30 days after first opening. Keep out of the reach of children.

Matropin 0.02 is a Product of the Generic Homatropine Hydrobromide

Matropin 0.02

Aristopharma Ltd. · Ophthalmic Solution

Homatropine Hydrobromide